Synuclein deposition and non-motor symptoms in Parkinson disease

Journal of the Neurological Sciences

Volumn 310, Issue 1-2, 2011, Pages 107-111

  Jellinger, Kurt A ^a  

^a INSTITUTE OF CLINICAL NEUROBIOLOGY   (Austria)

Author keywords

Synuclein pathology; Brainstem; Non motor features; Parkinson disease

Indexed keywords

ALPHA SYNUCLEIN; SYNUCLEIN;

ADRENAL MEDULLA; ADRENERGIC SYSTEM; ANXIETY DISORDER; APATHY; ARTICLE; AUTONOMIC DYSFUNCTION; BEHAVIOR DISORDER; BRAIN STEM; CLINICAL FEATURE; CONSTIPATION; CORRELATION ANALYSIS; DAYTIME SOMNOLENCE; DEMENTIA; DIFFUSE LEWY BODY DISEASE; DISEASE MODEL; DOPAMINERGIC ACTIVITY; DYSPHAGIA; HALLUCINATION; HUMAN; HYPERHIDROSIS; HYPOSMIA; INSOMNIA; MOTOR DYSFUNCTION; NEUROANATOMY; NOCTURIA; PAIN; PARASYMPATHETIC NERVE; PARKINSON DISEASE; PRIORITY JOURNAL; PSYCHOSIS; RESTLESS LEGS SYNDROME; SEBORRHEA; STRIDOR; SUBMANDIBULAR GLAND; SYNCOPE;

HUMANS; PARKINSON DISEASE; PERIPHERAL NERVES; SYNUCLEINS;

EID: 80054089850     PISSN: 0022510X     EISSN: 18785883     Source Type: Journal    
DOI: 10.1016/j.jns.2011.04.012     Document Type: Article

References (99)

1. K.R. Chaudhuri, and A.H. Schapira Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment Lancet Neurol 8 2009 464 474
2. R. Savica, W.A. Rocca, and J.E. Ahlskog When does Parkinson disease start? Arch Neurol 67 2010 798 801
3. K.R. Chaudhuri, E. Tolosa, A. Schapira, and W. Poewe Non-motor symptoms of Parkinson's disease 2009 Oxford Univ. Press
4. E. Tolosa, J. Santamaria, C. Gaig, and Y. Compta Nonmotor aspects of Parkinson's disease A.H.V. Schapira, A.E.T. Lang, S. Fahn, Movement disorders 4 2010 Saunders-Elsevier Philadelphia 229 251
5. W. Poewe Non-motor symptoms in Parkinson's disease Eur J Neurol 15 Suppl 1 2008 14 20 (Pubitemid 351421304)
6. D.A. Gallagher, A.J. Lees, and A. Schrag What are the most important nonmotor symptoms in patients with Parkinson's disease and are we missing them? Mov Disord 25 2010 2493 2500
7. A.D. Korczyn, and T. Gurevich Parkinson's disease: before the motor symptoms and beyond J Neurol Sci 289 2010 2 6
8. C. Juri, M. Rodriguez-Oroz, and J.A. Obeso The pathophysiological basis of sensory disturbances in Parkinson's disease J Neurol Sci 289 2010 60 65
9. T. Lebouvier, M. Neunlist, S. Bruley des Varannes, E. Coron, A. Drouard, and J.M. N'Guyen Colonic biopsies to assess the neuropathology of Parkinson's disease and its relationship with symptoms PLoS One 5 2010 e12728
10. M.C. Rodriguez-Oroz, M. Jahanshahi, P. Krack, I. Litvan, R. Macias, and E. Bezard Initial clinical manifestations of Parkinson's disease: features and pathophysiological mechanisms Lancet Neurol 8 2009 1128 1139
11. S.S. O'Sullivan, D.R. Williams, D.A. Gallagher, L.A. Massey, L. Silveira-Moriyama, and A.J. Lees Nonmotor symptoms as presenting complaints in Parkinson's disease: a clinicopathological study Mov Disord 23 2008 101 106 (Pubitemid 351281225)
12. A.E. Lang A critical appraisal of the premotor symptoms of Parkinson's disease: Potential usefulness in early diagnosis and design of neuroprotective trials Mov Disord 26 2011 775 783
13. K.R. Chaudhuri, and P. Odin The challenge of non-motor symptoms in Parkinson's disease Prog Brain Res 184 2010 325 341
14. C. Colosimo, L. Morgante, A. Antonini, P. Barone, T.P. Avarello, and E. Bottacchi Non-motor symptoms in atypical and secondary parkinsonism: the PRIAMO study J Neurol 257 2010 5 14
15. K.A. Jellinger Synucleinopathies Encyclop Movem Disord 3 2010 203 207
16. W.J. Schulz-Schaeffer The synaptic pathology of alpha-synuclein aggregation in dementia with Lewy bodies, Parkinson's disease and Parkinson's disease dementia Acta Neuropathol 120 2010 131 143
17. E. Kuusisto, L. Parkkinen, and I. Alafuzoff Morphogenesis of Lewy bodies: dissimilar incorporation of alpha-synuclein, ubiquitin, and p62 J Neuropathol Exp Neurol 62 2003 1241 1253 (Pubitemid 37494193)
18. H. Braak, D. Sandmann-Keil, W. Gai, and E. Braak Extensive axonal Lewy neurites in Parkinson's disease: a novel pathological feature revealed by alpha-synuclein immunocytochemistry Neurosci Lett 265 1999 67 69 (Pubitemid 29210200)
19. K.A. Jellinger A critical evaluation of current staging of alpha-synuclein pathology in Lewy body disorders Biochim Biophys Acta 1792 2009 730 740
20. I. Ferrer, A. Martinez, R. Blanco, E. Dalfo, and M. Carmona Neuropathology of sporadic Parkinson disease before the appearance of parkinsonism: preclinical Parkinson disease J Neural Transm 2010 10.1007/s00702-010-0482-8
21. A. Minguez-Castellanos, C.E. Chamorro, F. Escamilla-Sevilla, A. Ortega-Moreno, A.C. Rebollo, and M. Gomez-Rio Do alpha-synuclein aggregates in autonomic plexuses predate Lewy body disorders?: a cohort study Neurology 68 2007 2012 2018 (Pubitemid 46869706)
22. G.G. Kovacs, I.J. Milenkovic, M. Preusser, and H. Budka Nigral burden of alpha-synuclein correlates with striatal dopamine deficit Mov Disord 23 2008 1608 1612
23. T.G. Beach, C.H. Adler, L.I. Sue, L. Vedders, L. Lue, and C.L. White Iii Multi-organ distribution of phosphorylated alpha-synuclein histopathology in subjects with Lewy body disorders Acta Neuropathol 119 2010 689 702
24. K. Wakabayashi, F. Mori, K. Tanji, S. Orimo, and H. Takahashi Involvement of the peripheral nervous system in synucleinopathies, tauopathies and other neurodegenerative proteinopathies of the brain Acta Neuropathol 120 2010 1 12
25. G. Halliday, and K. Murphy Pathology of Parkinson's disease A.H.V. Schapira, A.E.T. Lang, S. Fahn, Movement disorders 4 2010 Saunders-Elsevier Philadelphia 132 154
26. L.T. Grinberg, U. Rueb, A.T. Alho, and H. Heinsen Brainstem pathology and non-motor symptoms in PD J Neurol Sci 289 2010 81 88
27. D.W. Dickson, H. Fujishiro, C. Orr, A. DelleDonne, K.A. Josephs, and R. Frigerio Neuropathology of non-motor features of Parkinson disease Parkinsonism Relat Disord 15 Suppl 3 2009 S1 S5
28. I. Ferrer Neuropathology and neurochemistry of nonmotor symptoms in Parkinson's disease Parkinsons Dis 2011 2011 708404 10.4061/2011/708404
29. H. Braak, K. Del Tredici, U. Rub, R.A. de Vos, E.N. Jansen Steur, and E. Braak Staging of brain pathology related to sporadic Parkinson's disease Neurobiol Aging 24 2003 197 211 (Pubitemid 36007810)
30. H. Braak, and K. Del Tredici Invited article: nervous system pathology in sporadic Parkinson disease Neurology 70 2008 1916 1925 (Pubitemid 351684646)
31. C.M. Muller, R.A. de Vos, C.A. Maurage, D.R. Thal, M. Tolnay, and H. Braak Staging of sporadic Parkinson disease-related alpha-synuclein pathology: inter- and intra-rater reliability J Neuropathol Exp Neurol 64 2005 623 628 (Pubitemid 40995277)
32. D.W. Dickson, H. Uchikado, H. Fujishiro, and Y. Tsuboi Evidence in favor of Braak staging of Parkinson's disease Mov Disord 25 Suppl 1 2010 S78 S82
33. A.E. Kingsbury, R. Bandopadhyay, L. Silveira-Moriyama, H. Ayling, C. Kallis, and W. Sterlacci Brain stem pathology in Parkinson's disease: an evaluation of the Braak staging model Mov Disord 25 2010 2508 2515
34. G.M. Halliday, K. Del Tredici, and H. Braak Critical appraisal of brain pathology staging related to presymptomatic and symptomatic cases of sporadic Parkinson's disease J Neural Transm Suppl 2006 99 103 (Pubitemid 44622185)
35. R.E. Burke, W.T. Dauer, and J.P. Vonsattel A critical evaluation of the Braak staging scheme for Parkinson's disease Ann Neurol 64 2008 485 491
36. T.G. Beach, C.H. Adler, L. Lue, L.I. Sue, J. Bachalakuri, and J. Henry-Watson Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction Acta Neuropathol 117 2009 613 634
37. K.A. Jellinger Formation and development of Lewy pathology: a critical update J Neurol 256 Suppl 3 2009 270 279
38. M.E. Kalaitzakis, M.B. Graeber, S.M. Gentleman, and R.K. Pearce The dorsal motor nucleus of the vagus is not an obligatory trigger site of Parkinson's disease: a critical analysis of alpha-synuclein staging Neuropathol Appl Neurobiol 34 2008 284 295 (Pubitemid 351590870)
39. L. Parkkinen, T. Pirttila, and I. Alafuzoff Applicability of current staging/categorization of alpha-synuclein pathology and their clinical relevance Acta Neuropathol 115 2008 399 407
40. A. Bloch, A. Probst, H. Bissig, H. Adams, and M. Tolnay Alpha-synuclein pathology of the spinal and peripheral autonomic nervous system in neurologically unimpaired elderly subjects Neuropathol Appl Neurobiol 32 2006 284 295
41. K.A. Jellinger Lewy body-related alpha-synucleinopathy in the aged human brain J Neural Transm 111 2004 1219 1235 (Pubitemid 39468387)
42. Y. Saito, N.N. Ruberu, M. Sawabe, T. Arai, H. Kazama, and T. Hosoi Lewy body-related alpha-synucleinopathy in aging J Neuropathol Exp Neurol 63 2004 742 749
43. J.E. Duda Olfactory system pathology as a model of Lewy neurodegenerative disease J Neurol Sci 289 2010 49 54
44. M. Witt, K. Bormann, V. Gudziol, K. Pehlke, K. Barth, and A. Minovi Biopsies of olfactory epithelium in patients with Parkinson's disease Mov Disord 24 2009 906 914
45. L. Silveira-Moriyama, J.L. Holton, A. Kingsbury, H. Ayling, A. Petrie, and W. Sterlacci Regional differences in the severity of Lewy body pathology across the olfactory cortex Neurosci Lett 453 2009 77 80
46. D.O. Claassen, K.A. Josephs, J.E. Ahlskog, M.H. Silber, M. Tippmann-Peikert, and B.F. Boeve REM sleep behavior disorder preceding other aspects of synucleinopathies by up to half a century Neurology 75 2010 494 499
47. B.F. Boeve REM sleep behavior disorder: updated review of the core features, the REM sleep behavior disorder-neurodegenerative disease association, evolving concepts, controversies, and future directions Ann NY Acad Sci 1184 2010 15 54
48. B.F. Boeve, M.H. Silber, C.B. Saper, T.J. Ferman, D.W. Dickson, and J.E. Parisi Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative disease Brain 130 2007 2770 2788 (Pubitemid 350033955)
49. A. Iranzo, and E. Tolosa REM sleep behaviour disorder in Parkinson's disease K.R. Chaudhuri, E. Tolosa, A. Schapira, W. Poewe, Non-motor symptoms of Parkinson's disease 2009 Oxford Univ. Press Oxford 177 193
50. R.B. Postuma, J.F. Gagnon, M. Vendette, C. Desjardins, and J.Y. Montplaisir Olfaction and color vision identify impending neurodegeneration in rapid eye movement sleep behavior disorder Ann Neurol 69 2010 811 818
51. N. Tachibana Historical overview of REM sleep behavior disorder in relation to its pathophysiology Brain Nerve 61 2009 558 568
52. Y.K. Kim, I.Y. Yoon, J.M. Kim, S.H. Jeong, K.W. Kim, and Y.K. Shin The implication of nigrostriatal dopaminergic degeneration in the pathogenesis of REM sleep behavior disorder Eur J Neurol 17 2010 487 492
53. H. Braak, R.A. de Vos, J. Bohl, and K. Del Tredici Gastric alpha-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology Neurosci Lett 396 2006 67 72 (Pubitemid 43233790)
54. H. Braak, M. Sastre, J.R. Bohl, R.A. de Vos, and K. Del Tredici Parkinson's disease: lesions in dorsal horn layer I, involvement of parasympathetic and sympathetic pre- and postganglionic neurons Acta Neuropathol 113 2007 421 429 (Pubitemid 46421631)
55. R.J. Phillips, G.C. Walter, S.L. Wilder, E.A. Baronowsky, and T.L. Powley Alpha-synuclein-immunopositive myenteric neurons and vagal preganglionic terminals: autonomic pathway implicated in Parkinson's disease? Neuroscience 153 2008 733 750
56. R. Sakakibara, T. Uchiyama, T. Yamanishi, K. Shirai, and T. Hattori Bladder and bowel dysfunction in Parkinson's disease J Neural Transm 115 2008 443 460
57. Y. Fumimura, M. Ikemura, Y. Saito, R. Sengoku, K. Kanemaru, and M. Sawabe Analysis of the adrenal gland is useful for evaluating pathology of the peripheral autonomic nervous system in Lewy body disease J Neuropathol Exp Neurol 66 2007 354 362 (Pubitemid 46701317)
58. E. Ghebremedhin, K. Del Tredici, J.W. Langston, and H. Braak Diminished tyrosine hydroxylase immunoreactivity in the cardiac conduction system and myocardium in Parkinson's disease: an anatomical study Acta Neuropathol 118 2009 777 784
59. S. Orimo, A. Takahashi, T. Uchihara, F. Mori, A. Kakita, and K. Wakabayashi Degeneration of cardiac sympathetic nerve begins in the early disease process of Parkinson's disease Brain Pathol 17 2007 24 30
60. S. Orimo, T. Uchihara, A. Nakamura, F. Mori, A. Kakita, and K. Wakabayashi Axonal alpha-synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinson's disease Brain 131 2008 642 650 (Pubitemid 351294710)
61. T. Amino, S. Orimo, Y. Itoh, A. Takahashi, T. Uchihara, and H. Mizusawa Profound cardiac sympathetic denervation occurs in Parkinson disease Brain Pathol 15 2005 29 34 (Pubitemid 40224064)
62. K. Kashihara, T. Imamura, and T. Shinya Cardiac 123I-MIBG uptake is reduced more markedly in patients with REM sleep behavior disorder than in those with early stage Parkinson's disease Parkinsonism Relat Disord 16 2010 252 255
63. T. Miyamoto, M. Miyamoto, M. Iwanami, and K. Hirata Cardiac (123)I-MIBG accumulation in Parkinson's disease differs in association with REM sleep behavior disorder Parkinsonism Relat Disord 17 2011 219 220
64. S. Orimo, T. Kanazawa, A. Nakamura, T. Uchihara, F. Mori, and A. Kakita Degeneration of cardiac sympathetic nerve can occur in multiple system atrophy Acta Neuropathol 113 2007 81 86 (Pubitemid 44782932)
65. M. Sone, M. Yoshida, Y. Hashizume, N. Hishikawa, and G. Sobue alpha-Synuclein-immunoreactive structure formation is enhanced in sympathetic ganglia of patients with multiple system atrophy Acta Neuropathol 110 2005 19 26 (Pubitemid 41131193)
66. G. Defazio, A. Berardelli, G. Fabbrini, D. Martino, E. Fincati, and A. Fiaschi Pain as a nonmotor symptom of Parkinson disease: evidence from a case-control study Arch Neurol 65 2008 1191 1194
67. M. Nolano, V. Provitera, A. Estraneo, M.M. Selim, G. Caporaso, and A. Stancanelli Sensory deficit in Parkinson's disease: evidence of a cutaneous denervation Brain 131 2008 1903 1911 (Pubitemid 351957457)
68. M. Ikemura, Y. Saito, R. Sengoku, Y. Sakiyama, H. Hatsuta, and K. Kanemaru Lewy body pathology involves cutaneous nerves J Neuropathol Exp Neurol 67 2008 945 953
69. R. Dabby, R. Djaldetti, M. Shahmurov, T.A. Treves, B. Gabai, and E. Melamed Skin biopsy for assessment of autonomic denervation in Parkinson's disease J Neural Transm 113 2006 1169 1176 (Pubitemid 44291012)
70. N.K. Archibald, M.P. Clarke, U.P. Mosimann, and D.J. Burn The retina in Parkinson's disease Brain 132 2009 1128 1145
71. R. Djaldetti, N. Lev, and E. Melamed Lesions outside the CNS in Parkinson's disease Mov Disord 24 2009 793 800
72. M.A. Hely, W.G. Reid, M.A. Adena, G.M. Halliday, and J.G. Morris The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years Mov Disord 23 2008 837 844
73. K.A. Jellinger The morphological basis of mental dysfunction in Parkinson's disease J Neurol Sci 248 2006 167 172 (Pubitemid 44647294)
74. K.A. Jellinger The neuropathologic substrate of Parkinson disease dementia Acta Neuropathol 119 2010 151 153
75. M.E. Kalaitzakis, and R.K. Pearce The morbid anatomy of dementia in Parkinson's disease Acta Neuropathol 118 2009 587 598
76. A.A. Kehagia, R.A. Barker, and T.W. Robbins Neuropsychological and clinical heterogeneity of cognitive impairment and dementia in patients with Parkinson's disease Lancet Neurol 9 2010 1200 1213
77. J.A. Sonnen, N. Postupna, E.B. Larson, P.K. Crane, S.E. Rose, and K.S. Montine Pathologic correlates of dementia in individuals with Lewy body disease Brain Pathol 20 2010 654 659
78. D. Aarsland, L. Marsh, and A. Schrag Neuropsychiatric symptoms in Parkinson's disease Mov Disord 24 2009 2175 2186
79. Y.M. Tian, X. Chen, D.Z. Luo, X.H. Zhang, H. Xue, and L.F. Zheng Alteration of dopaminergic markers in gastrointestinal tract of different rodent models of Parkinson's disease Neuroscience 153 2008 634 644
80. G. Anderson, A.R. Noorian, G. Taylor, M. Anitha, D. Bernhard, and S. Srinivasan Loss of enteric dopaminergic neurons and associated changes in colon motility in an MPTP mouse model of Parkinson's disease Exp Neurol 207 2007 4 12 (Pubitemid 47332479)
81. T. Chaumette, T. Lebouvier, P. Aubert, B. Lardeux, C. Qin, and Q. Li Neurochemical plasticity in the enteric nervous system of a primate animal model of experimental Parkinsonism Neurogastroenterol Motil 21 2009 215 222
82. S.H. Fox, and J.M. Brotchie The MPTP-lesioned non-human primate models of Parkinson's disease. Past, present, and future Prog Brain Res 184 2010 133 157
83. L. Wang, S.M. Fleming, M.F. Chesselet, and Y. Tache Abnormal colonic motility in mice overexpressing human wild-type alpha-synuclein Neuroreport 19 2008 873 876 (Pubitemid 351655158)
84. Y.M. Kuo, Z. Li, Y. Jiao, N. Gaborit, A.K. Pani, and B.M. Orrison Extensive enteric nervous system abnormalities in mice transgenic for artificial chromosomes containing Parkinson disease-associated alpha-synuclein gene mutations precede central nervous system changes Hum Mol Genet 19 2010 1633 1650
85. J.G. Greene, A.R. Noorian, and S. Srinivasan Delayed gastric emptying and enteric nervous system dysfunction in the rotenone model of Parkinson's disease Exp Neurol 218 2009 154 161
86. R.E. Drolet, J.R. Cannon, L. Montero, and J.T. Greenamyre Chronic rotenone exposure reproduces Parkinson's disease gastrointestinal neuropathology Neurobiol Dis 36 2009 96 102
87. F.J. Pan-Montojo, and R.H. Funk Oral administration of rotenone using a gavage and image analysis of alpha-synuclein inclusions in the enteric nervous system J Vis Exp 2010
88. T.N. Taylor, W.M. Caudle, K.R. Shepherd, A. Noorian, C.R. Jackson, and P.M. Iuvone Nonmotor symptoms of Parkinson's disease revealed in an animal model with reduced monoamine storage capacity J Neurosci 29 2009 8103 8113
89. P. Jenner Functional models of Parkinson's disease: a valuable tool in the development of novel therapies Ann Neurol 64 Suppl 2 2008 S16 S29
90. A.C. Vernon Mice with reduced vesicular monoamine storage content display nonmotor features of Parkinson's disease J Neurosci 29 2009 12,842 12,844
91. S. Stemberger, W. Poewe, G.K. Wenning, and N. Stefanova Targeted overexpression of human alpha-synuclein in oligodendroglia induces lesions linked to MSA-like progressive autonomic failure Exp Neurol 224 2010 459 464
92. C. Singaram, W. Ashraf, E.A. Gaumnitz, C. Torbey, A. Sengupta, and R. Pfeiffer Dopaminergic defect of enteric nervous system in Parkinson's disease patients with chronic constipation Lancet 346 1995 861 864
93. A.E. Lang, and A.M. Lozano Parkinson's disease. First of two parts N Engl J Med 339 1998 1044 1053 (Pubitemid 28457867)
94. H. Bernheimer, W. Birkmayer, O. Hornykiewicz, K. Jellinger, and F. Seitelberger Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations J Neurol Sci 20 1973 415 455
95. H.C. Cheng, C.M. Ulane, and R.E. Burke Clinical progression in Parkinson disease and the neurobiology of axons Ann Neurol 67 2010 715 725
96. A. DelleDonne, K.J. Klos, H. Fujishiro, Z. Ahmed, J.E. Parisi, and K.A. Josephs Incidental Lewy body disease and preclinical Parkinson disease Arch Neurol 65 2008 1074 1080
97. L.S. Forno Concentric hyalin intraneuronal inclusions of Lewy type in the brains of elderly persons (50 incidental cases): relationship to parkinsonism J Am Geriatr Soc 17 1969 557 575
98. L. Parkkinen, T. Pirttila, M. Tervahauta, and I. Alafuzoff Widespread and abundant alpha-synuclein pathology in a neurologically unimpaired subject Neuropathology 25 2005 304 314 (Pubitemid 43943239)
99. C. Colosimo, A.J. Hughes, L. Kilford, and A.J. Lees Lewy body cortical involvement may not always predict dementia in Parkinson's disease J Neurol Neurosurg Psychiatry 74 2003 852 856 (Pubitemid 36782982)